News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Unveils Sweeping Pharma, Biotech, and Medical Device Reforms
Thursday, January 15, 2026The EU has announced comprehensive reforms to streamline approvals reduce bureaucracy and boost innovation in the pharma biotech and medical device sectors
Kye Pharmaceuticals signs licensing and distribution agreement with Neurim for SLENYTO® in Canada
Wednesday, January 14, 2026Kye Pharmaceuticals a Canadian specialty pharmaceutical company has entered into a licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO extendedrelease melatonin in Canada
TetraScience Collaborates with Thermo Fisher Scientific to Advance Scientific Data and AI in Laboratories
Tuesday, January 13, 2026TetraScience has announced a collaboration with Thermo Fisher Scientific aimed at accelerating the use of artificial intelligence across biopharmaceutical research development and manufacturing
FDA Accepts New Drug Application for Pimicotinib in Tenosynovial Giant Cell Tumour
Tuesday, January 13, 2026Merck has announced that the US Food and Drug Administration FDA has accepted its new drug application for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumour TGCT
Insmed Plans BRINSUPRI Launch in European Union in First Half of 2026 Following Regulatory Progress
Monday, January 12, 2026Insmed Incorporated announced plans to launch its inhaled treprostinil therapy BRINSUPRI in the European Union during the first half of marking a key expansion in rare disease treatments
ENYO Pharma reports positive Phase 2 data for vonafexor in Alport syndrome and prepares pivotal Phase 3 programme
Friday, January 09, 2026Lyonbased ENYO Pharma has announced positive Phase Alpestria data for vonafexor in Alport syndrome and is now preparing a pivotal Phase programme and broader renal pipeline strategy
ViCentra Secures Additional $13 Million to Expand European Manufacturing and Commercial Footprint for Kaleido Insulin Patch Pump
Thursday, January 08, 2026ViCentra has expanded its Series D financing to million with an additional million to scale manufacturing and commercial operations for its Kaleido insulin patch pump across key European markets
Lilly to Acquire Ventyx Biosciences to Strengthen Oral Treatments for Inflammatory Diseases
Thursday, January 08, 2026Eli Lilly and Company has entered into a definitive agreement to acquire Ventyx Biosciences a clinicalstage biopharmaceutical company based in San Diego The acquisition aims to expand Lillys
Basilea Pharmaceutica and Prokaryotics Announce Strategic Collaboration for Novel Broad-Spectrum Antifungal Development
Wednesday, January 07, 2026Swiss biopharma leader Basilea Pharmaceutica enters exclusive global collaboration with USbased Prokaryotics to advance a firstinclass antifungal program addressing severe invasive infections
Oculis Receives U.S. FDA Breakthrough Therapy Designation for Privosegtor in Optic Neuritis
Wednesday, January 07, 2026Oculis Holding AG a global biopharmaceutical company focused on neuroophthalmology and ophthalmology has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for Privosegtor for the treatment of optic neuritis
